# Universal CAR-T Cell Therapy for NHL

> **NCT07248163** · NA · RECRUITING · sponsor: **Bioray Laboratories** · enrollment: 6 (estimated)

## Conditions studied

- Non-hodgkin Lymphoma,B Cell

## Interventions

- **DRUG:** BRL-301

## Key facts

- **NCT ID:** NCT07248163
- **Lead sponsor:** Bioray Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-11
- **Primary completion:** 2027-08-15
- **Final completion:** 2028-03-11
- **Target enrollment:** 6 (ESTIMATED)
- **Last updated:** 2025-11-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07248163

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07248163, "Universal CAR-T Cell Therapy for NHL". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07248163. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*